Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine for wheezing in pediatric allergic rhinitis
NCT03340740Phase 4Completed
- Sponsor
- NYC Health + Hospitals
- Start
- May 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetirizine in allergic rhinitis (AR), asthma, sponsored by NYC Health + Hospitals. Started May 2018; status: completed.
02
Drugs
cetirizine
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on NCT03340740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340740.